Drugs / CBD-OS
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT07233239 | Nov 2025 → Nov 2027 expected | focal epilepsy | Jazz Pharmaceuticals | Recruiting | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | CBD-OS | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07233239 ↗ |